Clinical Trials Sponsored by Ventracor

Total 6 results

Pentracor GmbH

Withdrawn

CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19 (CAPMYKCO)

Covid19

Germany
Pentracor GmbH

Terminated

CASTRO1 - Study on CRP Apheresis After Ischemic Stroke (CASTRO1)

Stroke, Ischemic

Germany
Pentracor GmbH

Completed

Study on CRP Apheresis After Coronary Bypass Surgery (CABY1)

Post-cardiac Surgery

Germany
Ventracor
International Center for Health Outcomes and Innovation Research

Unknown

VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy

Cardiomyopathies | End-stage Heart Failure

United States
Ventracor
International Center for Health Outcomes and Innovation Research

Unknown

VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial

Cardiomyopathies | End-stage Heart Failure

United States
Ventracor
International Center for Health Outcomes and Innovation Research

Completed

VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial

Cardiomyopathies | End-Stage Heart Failure

United States

3

Subscribe